With Round 1 Fully Sold Out, ClinTex Launches Round 2 of the CTi Token Sale

Bitcoin Press Release: With the first tier of ClinTex’s CTi token sale 100% sold-out, the second phase has now begun, with 70% bonuses available.

 

1st October 2020, London, United Kingdom: The lack of coordination, and major issues with bureaucracy are taking a heavy toll on the medical trials industry. Costing anywhere from $600,000 to upto $8 million USD per day, every single day a medicine is delayed not only leads to huge financial losses, but also affects millions of people as they are deprived of crucial, life saving drugs. 

 

And ClinTex’s solution comes at the perfect time – With the disruption of the $350bn/year medical trials market firmly in their sights via a novel solution to bring down costs, reduce friction and increase efficiency and information transfer, ClinTex has successfully completed its first round of token distribution, selling out $1m USD of tokens.

 

Tier 2 CTi Presale

Following the success of the first sale round, ClinTex have opened up the sale to participants wishing to join the action by acquiring CTi tokens. A total of 26,666,667 CTi are available in this round. ClinTex eventually plans for an IEO, but participants of Tier 2 can take advantage to back the platform’s CTi with a 40% bonus, getting their hands on each token at $0.075 per CTi. Half of all the tokens purchased in this round will be vested for a period of 2 months.

 

Proceeds from this event will be used to develop the platform and bring a change to how the current medical trial and healthcare industry is working.

 

About ClinTex

Leveraging blockchain technology, ClinTex is on a path to eliminate barriers and friction in the current medical industry that waste millions of dollars per day. ClinTex brings changes such as:

 

  • Time Saving: Normally, it takes up to 15 years for a drug to pass all trials and into the hands of patients, a time that many might not have. ClinTex’s well coordinated platform will reduce the friction that causes time delays.
  • Research Silos: Currently, the medical research industry is in disarray when it comes to communicating with each other. Two or even more firms may be spending time looking into the same medicine, leading to waste of time and resources. ClinTex’s transparency will bring in close coordination, letting one team work on an issue while the other takes up something else.
  • Cheaper Medicine: With the close coordination within the research community, development and supply chain, the patients eventually get a medicine that is cheaper, essentially saving lives.

 

The importance of a close-knit healthcare industry has never been more important. The current pandemic has exposed how weak the medical industry is when faced with a crisis that does not care for borders and race.

 

Join the presale today and take advantage of a 40% discount.

 

Visit ClinTex Website: https://www.clintex.io/ 

Join the ClinTex Telegram Community: https://t.me/ClinTexCTi 

Follow ClinTex on Twitter: https://twitter.com/ClinTexCTi 

Check out ClinTex Medium: https://medium.com/@clintexcti 

 

Media Contact Details 

Contact Name: Sean Flanagan

Contact Email: info@clintex.io

.

About Bitcoin PR Buzz: Bitcoin PR Buzz has been proudly serving the crypto press release distribution needs of blockchain start-ups for over 8 years. Get your Bitcoin Press Release Distribution today.

 

ClinTex is the source of this content. This press release is for informational purposes only. The information does not constitute investment advice or an offer to invest. The ClinTex token sale is closed to US participants and participants of all countries in which ICO/IEOs are illegal. Virtual currency is not legal tender, is not backed by the government, and accounts and value balances are not subject to consumer protections. Token sales are only suitable for individuals with a high risk tolerance. Only participate in a token event with what you can afford to lose.

 

The post With Round 1 Fully Sold Out, ClinTex Launches Round 2 of the CTi Token Sale appeared first on Bitcoin PR Buzz.

Bitcoin PR Buzz – Massive Exposure For Bitcoin Services, Projects, and Merchants

Source: BRPB Feed

In the Age of Coronavirus, the Medical Trials Market Could Offer Better Returns than DeFi

DeFi action within blockchain has been one of 2020’s most unexpected twists of fate. The start of the year brought unprecedented uncertainty, recession, and fear to markets far and wide, on a global scale. But good things come to those who wait, and Blockchain’s revival in late 2020 seems to be the silver lining all of us were praying for.

And DeFi itself feels like Blockchain’s calling – a realisation of the original mission to provide a decentralised medium of transfer, meeting with the needs of an increasingly technological and financially-savvy society. That’s why interest has boomed, and we’re seeing some truly groundbreaking returns – A quick look at top providers shows that the heralded rates of 6-7% annual returns of yesteryear are a thing of the past. 

 

With rates creeping up over 10% for “safe” investment classes, it’s not uncommon to see over 50% returns touted for less reputable asset classes and investment pools. What’s not surprising then, is that new investors and experienced alike are being drawn into malicious and bad-actor schemes. Not to mention, most DeFi projects are all but middlemen for traditional investment schemes, acting as a guarantor.

 

With the DeFi wave stabilising, and information inefficiencies ironing out, the market begins to ask – “where from here?”. It’s clear that the drawbacks of DeFi are impacting the market, and educated assessments of less-apparent opportunities are showing higher potential profits on closer inspection.

 

COVID-19: The Overlooked Opportunity

Check the news today. Did you hear a story about COVID-19? Chances are, your answer was yes. But with the hysteria over, and more rational conversations about solutions to COVID-19 beginning, we ask – Where are the opportunities? Well, it all lies in a number:

 

The cost of getting a new drug to market today, is $2,500,000,000. That’s right – Not $25 million, not even $250 million. $2.5 billion. And what’s more, up to $8,000,000 per day is lost via revenue erosion, resulting from delays of getting medicines to market. The market for medical trials and the opportunities for a smart system to reduce revenue erosion are massive.

Back to that number. 3017 is the number of clinical trials currently in process or awaiting commencement to test vaccines for COVID-19. And with government contracts awaiting worldwide for a first-out-the-door solution, the race is on. And for an industry wracked by inefficiencies like time delays, lack of collaboration between providers, the industry yearns for a solution, one which could provide extremely competitive returns even when sat next to the current industry DeFi craze.

 

CTi: The Solution to DeFi, and Capturer of the $3.5bn Market?

Luckily one startup, ClinTex, recognised the opportunity presenting itself in the clinical trials market, and decided to use blockchain and machine learning to access the untapped potential of inefficiencies in the pharmaceutical industry. 

 

ClinTex’s platform will reduce lead time for new drugs, improve cross-collaboration in the global medicines market for the betterment of humanity, vastly increase data collection and storage including immutability, and most importantly, reduce by an unfathomable amount the high cost of clinical trials in new drug development. 

 

What’s more, is that ClinTex are currently offering interested parties the opportunity to own their native token CTi through their token pre-sale at a 50% discounted rate, which will allow them access to the clinical trials ecosystem. And with such a large market to be tapped, the tokens look likely to become hot property in the wake of the COVID-19 pandemic. 

 

With all of ClinTex’s benefits, it doesn’t take a stretch of the imagination to envision how CTi could well be instrumental in bringing globally disjointed efforts together to bring forth life-saving vaccines, as well as countless other necessary medicines – Think cancer treatments, AIDS, and other “incurable” diseases. All is possible in the future of CTi.

 

To join the CTi presale today and get 50% off, visit https://www.clintex.io/presale

 

ClinTex is the sole source of this information.Virtual currency is not legal tender, is not backed by the government, and accounts and value balances are not subject to consumer protections. This press release is for informational purposes only. The information does not constitute investment advice or an offer to invest.

About Bitcoin PR Buzz: Bitcoin PR Buzz has been proudly serving the crypto press release distribution needs of blockchain start-ups for over 8 years. Get your Bitcoin Press Release Distribution today.

 

The post In the Age of Coronavirus, the Medical Trials Market Could Offer Better Returns than DeFi appeared first on Bitcoin PR Buzz.

Bitcoin PR Buzz – Massive Exposure For Bitcoin Services, Projects, and Merchants

Source: BRPB Feed